William White
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
William R.
White is currently Director at Disc Medicine Opco, Inc. since 2021, Independent Director at Disc Medicine, Inc. since 2020, and Director at Yarrow Bioscience, Inc. Formerly, Mr. White was Managing Director-Healthcare Investment Banking at Citigroup, Inc. from 2006 to 2017, Independent Director at Ventyx Biosciences, Inc. from 2021 to 2026, CFO, Treasurer, EVP & Head-Corporate Development at Akero Therapeutics, Inc. from 2019 to 2025, Head-US Life Sciences Investment Banking at Deutsche Bank Corp.
from 2017 to 2019, Vice President-Healthcare Investment Banking at Goldman Sachs & Co. LLC from 2004 to 2006, Attorney at Sullivan & Cromwell LLP from 1998 to 1999, and Director at Gemini Therapeutics, Inc. Education includes graduate degrees from The Trustees of Columbia University in The City of New York and Harvard University, and an undergraduate degree from Princeton University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DISC MEDICINE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DISC MEDICINE, INC. | Directeur/Membre du Conseil | 01/12/2020 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Directeur/Membre du Conseil | 13/01/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Directeur/Membre du Conseil | 04/03/2026 |
| AKERO THERAPEUTICS, INC. | Directeur Financier/CFO | 09/12/2025 |
Deutsche Bank Corp.
Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Corporate Officer/Principal | 01/03/2019 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/09/2017 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/03/2006 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sullivan & Cromwell LLP
Sullivan & Cromwell LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank Corp.
Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Finance |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national